Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a ...

New @hopkinskimmel research finds extra copies of chromosome 1q may drive the earliest stages of pancreatic cancer. › ...

It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...

Valar Labs is a precision oncology company using artificial intelligence to reduce the uncertainty in cancer treatment. By analyzing standard pathology slides, Valar's AI biomarkers predict response ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors. Now, researchers at University of California San Diego School of Medicine ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows. Led by ...